Full reference for Body Protection Compound 157 — mechanism, evidence table, oral vs injectable protocols, safety profile, and current COA-verified vendor pricing.
Research context only. This page is for educational purposes based on published data. Not medical advice.
BPC-157 operates through multiple parallel pathways — part of what makes it unusually versatile. Core mechanisms include VEGF-driven angiogenesis, growth factor upregulation (EGF, FGF, PDGF), nitric oxide system modulation, and direct effects on fibroblast activity and collagen synthesis.
Its gut-specific mechanism involves maintaining the integrity of the mucosal lining, upregulating cytoprotective prostaglandins, and modulating the enteric nervous system. This is the most well-characterized mechanism — the gastric juice origin of BPC makes the GI activity the most directly applicable.
The NO paradox: BPC-157 both upregulates and downregulates nitric oxide production depending on context. In vascular repair, it promotes NO synthesis; in inflammatory contexts, it suppresses excessive NO that causes tissue damage. This context-dependent activity is part of why it produces favorable outcomes across different tissue types.
| Application | Evidence Level | Key Findings |
|---|---|---|
| Gut / GI healing | Strong (animal) | Mucosal repair, NSAID damage reversal, IBD models, ulcer healing |
| Tendon healing | Strong (animal) | Achilles tendon reattachment, collagen organization, faster return to function |
| Ligament repair | Strong (animal) | MCL and ACL models show accelerated healing |
| Bone healing | Moderate (animal) | Fracture repair acceleration, bone density support |
| Nerve repair | Moderate (animal) | Peripheral nerve regeneration, neuroprotection |
| CNS / mood | Emerging (animal) | Dopamine/serotonin modulation, antidepressant-like effects |
| Human clinical | No formal trials | Extensive community use data; no Phase 1/2/3 trials completed |
| Application | Dose | Route | Frequency |
|---|---|---|---|
| General systemic healing | 250–500 mcg | SubQ | Daily |
| Local injury | 200–300 mcg | SubQ near site | Daily |
| GI / gut healing | 250 mcg | Oral (fasted) | Daily |
| Cycle length | 4–12 weeks | — | Acute: 4–6 wks; chronic: 8–12 wks |
COA-verified vendor pricing with promo codes, reconstitution guide, and dosing protocol.
View Pricing → Dosage Calculator